Advertisement

Topics

Pharma company opens R&D centre in Hull for addiction treatment

06:22 EDT 24 Aug 2017 | EPM Magazine

Indivior, a speciality pharmaceutical company, has opened a $30 million research and development (R&D) centre in Hull, UK, to further advance its treatment innovation into the global addiction crisis.

Original Article: Pharma company opens R&D centre in Hull for addiction treatment

NEXT ARTICLE

More From BioPortfolio on "Pharma company opens R&D centre in Hull for addiction treatment"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...